Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) saw a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 9,026 shares, an increase of 319.0% from the June 30th total of 2,154 shares. Based on an average trading volume of 90,174 shares, the short-interest ratio is currently 0.1 days.
Ono Pharmaceutical Stock Performance
Ono Pharmaceutical stock opened at $4.93 on Friday. The company has a 50-day moving average price of $4.84 and a 200 day moving average price of $5.00. Ono Pharmaceutical has a 12-month low of $3.55 and a 12-month high of $5.75.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Further Reading
- Five stocks we like better than Ono Pharmaceutical
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
- 2 Stocks Built to Thrive If Inflation Refuses to Fade
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
